Initiator Pharma A/S (STO:INIT)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.740
+0.040 (1.08%)
Jul 16, 2025, 5:20 PM CET
-58.67%
Market Cap252.48M
Revenue (ttm)n/a
Net Income (ttm)-16.67M
Shares Out68.24M
EPS (ttm)-0.30
PE Ration/a
Forward PE4.80
Dividendn/a
Ex-Dividend Daten/a
Volume89,268
Average Volume55,308
Open3.700
Previous Close3.700
Day's Range3.640 - 3.890
52-Week Range3.300 - 9.400
Beta0.22
RSI39.33
Earnings DateAug 22, 2025

About Initiator Pharma

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes Pudafensine, a monoamine reuptake inhibitor primarily targeting the dopamine system for both treatment resistant organic erectile dysfunction and neuropathic pain in Phase 2b clinical trials; IP2018, a monoamine reuptake inhibitor completed Phase 2a for the treatment of psychogenic erectile dysfunction; and IP2016, which is in preclinical development for the tre... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol INIT
Full Company Profile

Financial Performance

Financial numbers in DKK Financial Statements

News

There is no news available yet.